Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT2080221246Phase 3Completed
Phase 3 trial of Zoster vaccine recombinant in herpes zoster (HZ) (2 arms). Started Sep 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT2080221246.